Heather Gornik, MD, is co-director of the Vascular Center at University Hospitals Harrington Heart & Vascular Institute. A cardiologist and vascular medicine specialist, Dr. Gornik completed medical school at the University of Chicago. She went on to receive additional training in internal medicine, cardiology, and vascular medicine at Brigham and Women's Hospital, Harvard Medical School in Boston where she also served as chief medical resident. She previously worked at Cleveland Clinic for 13 years, where she was the Medical Director of the Non-Invasive Vascular Laboratories and Section Head of Vascular Medicine.
Dr. Gornik is an internationally recognized expert in the care of complex vascular diseases, particularly fibromuscular dysplasia (FMD), an uncommon disease of the arteries that can lead to narrowing, aneurysm and dissection. She currently serves as a member of the Medical Advisory Board of the Fibromuscular Dysplasia Society of America (FMDSA), and serves on the steering committee of the United States Registry for FMD. She collaborates with clinicians and investigators worldwide to advance the understanding of this potentially morbid vascular disease. In addition to her work in FMD, Dr. Gornik is a nationally regarded expert in noninvasive vascular diagnostic testing and serves as the President of the Vascular Testing Division of the Intersocietal Accreditation Commission (IAC).
Dr. Gornik has led the development of national guidelines related to the diagnosis and clinical care pathways for patients with vascular disease. She is currently the President of the Society for Vascular Medicine and serves as Editor-in-Chief of its official journal, Vascular Medicine.
- Arterial Dissection
- Cardiovascular Medicine
- Fibromuscular Dysplasia
- Peripheral Vascular Disorders
- Vascular Medicine
- Vascular Ultrasound
- Cardiovascular Disease - American Board of Internal Medicine
Fellowship | Vascular Medicine
Vascular Medicine - Brigham And Women's Hospital (2004 - 2005)
Residency | Internal Medicine/Chief Resident
Internal Medicine/Chief Resident - Brigham And Women's Hospital (2002 - 2003)
Fellowship | Cardiology
Cardiology - Brigham And Women's Hospital (2000 - 2004)
Residency | Internal Medicine
Internal Medicine - Brigham And Women's Hospital (1998 - 2000)
Internship | Internal Medicine
Internal Medicine - Brigham And Women's Hospital (1997 - 1998)
Harvard Medical School (2005)
University Of Chicago Pritzker School Of Medicine (1997)
Johns Hopkins Bloomberg School Of Public Health (1994)
Johns Hopkins University (1992)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Heather Gornik did not disclose any Outside Relationships with Industry.